Literature DB >> 25842366

Hepatocyte growth factor activator inhibitor type 1 maintains the assembly of keratin into desmosomes in keratinocytes by regulating protease-activated receptor 2-dependent p38 signaling.

Makiko Kawaguchi1, Ai Kanemaru1, Akira Sawaguchi2, Koji Yamamoto3, Takashi Baba4, Chen-Yong Lin5, Michael D Johnson5, Tsuyoshi Fukushima1, Hiroaki Kataoka6.   

Abstract

Hepatocyte growth factor activator inhibitor type 1 (HAI-1; official symbol SPINT1) is a membrane-associated serine proteinase inhibitor abundantly expressed in epithelial tissues. Genetically engineered mouse models demonstrated that HAI-1 is critical for epidermal function, possibly through direct and indirect regulation of cell surface proteases, such as matriptase and prostasin. To obtain a better understanding of the role of HAI-1 in maintaining epidermal integrity, we performed ultrastructural analysis of Spint1-deleted mouse epidermis and organotypic culture of an HAI-1 knockdown (KD) human keratinocyte cell line, HaCaT. We found that the aggregation of tonofilaments to desmosomes was significantly reduced in HAI-1-deficient mouse epidermis with decreased desmosome number. Similar findings were observed in HAI-1 KD HaCaT organotypic cultures. Immunoblot and immunohistochemical analyses revealed that p38 mitogen-activated protein kinase was activated in response to HAI-1 insufficiency. Treatment of HAI-1 KD HaCaT cells with a p38 inhibitor abrogated the above-observed ultrastructural abnormalities. The activation of p38 induced by the loss of HAI-1 likely resulted from enhanced signaling of protease-activated receptor-2 (PAR-2), because its silencing abrogated the enhanced activation of p38. Consequently, treatment of HAI-1 KD HaCaT cells with a serine protease inhibitor, aprotinin, or PAR-2 antagonist alleviated the abnormal ultrastructural phenotype in organotypic culture. These results suggest that HAI-1 may have a critical role in maintaining normal keratinocyte morphology through regulation of PAR-2-dependent p38 mitogen-activated protein kinase signaling.
Copyright © 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25842366      PMCID: PMC5707200          DOI: 10.1016/j.ajpath.2015.02.009

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  53 in total

Review 1.  Barrier function of the skin: "la raison d'être" of the epidermis.

Authors:  Kathi C Madison
Journal:  J Invest Dermatol       Date:  2003-08       Impact factor: 8.551

2.  p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris.

Authors:  Xuming Mao; Yasuyo Sano; Jin Mo Park; Aimee S Payne
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

3.  TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.

Authors:  Tomio Hashimoto; Minoru Kato; Takeshi Shimomura; Naomi Kitamura
Journal:  FEBS J       Date:  2010-10-26       Impact factor: 5.542

4.  Localization of hepatocyte growth factor activator inhibitor type 1 in Langhans' cells of human placenta.

Authors:  H Kataoka; J Y Meng; H Itoh; R Hamasuna; T Shimomura; T Suganuma; M Koono
Journal:  Histochem Cell Biol       Date:  2000-12       Impact factor: 4.304

5.  Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis.

Authors:  Karin List; Christian C Haudenschild; Roman Szabo; WanJun Chen; Sharon M Wahl; William Swaim; Lars H Engelholm; Niels Behrendt; Thomas H Bugge
Journal:  Oncogene       Date:  2002-05-23       Impact factor: 9.867

6.  Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation.

Authors:  Karin List; Roman Szabo; Alfredo Molinolo; Virote Sriuranpong; Vivien Redeye; Tricia Murdock; Beth Burke; Boye S Nielsen; J Silvio Gutkind; Thomas H Bugge
Journal:  Genes Dev       Date:  2005-08-15       Impact factor: 11.361

7.  The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.

Authors:  Stine Friis; Katiuchia Uzzun Sales; Jeffrey Martin Schafer; Lotte K Vogel; Hiroaki Kataoka; Thomas H Bugge
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

8.  Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome.

Authors:  Katiuchia Uzzun Sales; Andrius Masedunskas; Alexandra L Bey; Amber L Rasmussen; Roberto Weigert; Karin List; Roman Szabo; Paul A Overbeek; Thomas H Bugge
Journal:  Nat Genet       Date:  2010-07-25       Impact factor: 38.330

9.  The epidermal barrier function is dependent on the serine protease CAP1/Prss8.

Authors:  Céline Leyvraz; Roch-Philippe Charles; Isabelle Rubera; Marjorie Guitard; Samuel Rotman; Bernadette Breiden; Konrad Sandhoff; Edith Hummler
Journal:  J Cell Biol       Date:  2005-08-01       Impact factor: 10.539

10.  p38 MAPK Signaling in Pemphigus: Implications for Skin Autoimmunity.

Authors:  Athanasios Mavropoulos; Timoklia Orfanidou; Christos Liaskos; Daniel S Smyk; Vassiliki Spyrou; Lazaros I Sakkas; Eirini I Rigopoulou; Dimitrios P Bogdanos
Journal:  Autoimmune Dis       Date:  2013-07-10
View more
  8 in total

1.  The crystal structure of a multidomain protease inhibitor (HAI-1) reveals the mechanism of its auto-inhibition.

Authors:  Min Liu; Cai Yuan; Jan K Jensen; Baoyu Zhao; Yunbin Jiang; Longguang Jiang; Mingdong Huang
Journal:  J Biol Chem       Date:  2017-03-27       Impact factor: 5.157

2.  The Kunitz-type serine protease inhibitor Spint2 is required for cellular cohesion, coordinated cell migration and cell survival during zebrafish hatching gland development.

Authors:  Julia Hatzold; Heike Wessendorf; Hans-Martin Pogoda; Wilhelm Bloch; Matthias Hammerschmidt
Journal:  Dev Biol       Date:  2021-04-04       Impact factor: 3.148

3.  Hepatocyte growth factor activator inhibitor-2 stabilizes Epcam and maintains epithelial organization in the mouse intestine.

Authors:  Makiko Kawaguchi; Koji Yamamoto; Naoki Takeda; Tsuyoshi Fukushima; Fumiki Yamashita; Katsuaki Sato; Kenichiro Kitamura; Yoshitaka Hippo; James W Janetka; Hiroaki Kataoka
Journal:  Commun Biol       Date:  2019-01-04

4.  PAR-2 promotes cell proliferation, migration, and invasion through activating PI3K/AKT signaling pathway in oral squamous cell carcinoma.

Authors:  Kai-Liang Tang; Han-Ying Tang; Yi Du; Tian Tian; Shi-Jiang Xiong
Journal:  Biosci Rep       Date:  2019-07-05       Impact factor: 3.840

5.  Comprehensive Analysis of the Expression and Prognostic Value of SPINT1/2 in Breast Carcinoma.

Authors:  Qiulin Wu; Guobing Yin; Jing Luo; Yingzi Zhang; Tiantian Ai; Jiao Tian; Yudi Jin; Jinwei Lei; Shengchun Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-26       Impact factor: 5.555

6.  Insufficiency of hepatocyte growth factor activator inhibitor-1 confers lymphatic invasion of tongue carcinoma cells.

Authors:  Aya Izumi; Koji Yamamoto; Makiko Kawaguchi; Fumiki Yamashita; Tsuyoshi Fukushima; Takumi Kiwaki; Hiroyuki Tanaka; Yoshihiro Yamashita; Hiroaki Kataoka
Journal:  Cancer Sci       Date:  2022-04-12       Impact factor: 6.518

7.  Inhibition of nuclear factor-κB signaling suppresses Spint1-deletion-induced tumor susceptibility in the ApcMin/+ model.

Authors:  Makiko Kawaguchi; Koji Yamamoto; Ai Kanemaru; Hiroyuki Tanaka; Kazuo Umezawa; Tsuyoshi Fukushima; Hiroaki Kataoka
Journal:  Oncotarget       Date:  2016-10-18

8.  Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells.

Authors:  Koji Yamamoto; Makiko Kawaguchi; Takeshi Shimomura; Aya Izumi; Kazuomi Konari; Arata Honda; Chen-Yong Lin; Michael D Johnson; Yoshihiro Yamashita; Tsuyoshi Fukushima; Hiroaki Kataoka
Journal:  Oncotarget       Date:  2018-02-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.